Distributional analyses for children's inhalation risk assessments

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 71, Issue 3, 2008, Pages 218-226

  Hattis, Dale ^a  

^a CLARK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULTHOOD; ARTICLE; CHILD; CHILDHOOD; DATA BASE; HUMAN; INHALATION; MEDICAL PARAMETERS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESPIRATORY SYSTEM; RISK ASSESSMENT; TOXICOLOGY; UNCERTAINTY; VARIANCE;

ADULT; CHILD, PRESCHOOL; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; MODELS, STATISTICAL; RISK ASSESSMENT; UNCERTAINTY;

EID: 37549006807     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390701598150     Document Type: Article

References (34)

1. Baird, S. J. S., Cohen, J. T., Graham, J. D., Shlyakhter, A. I., and Evans, J. S. 1996. Noncancer risk assessment: A probabilistic alternative to current practice. Hum. Ecol. Risk Assess. 2:78-99.
2. Bakke, S., Baste, V., and Gulsvik, A. 1991. Bronchial responsiveness in a Norwegian community. Am. Rev. Respir. Dis. 143:317-322.
3. Balmes, J. R., Aris, R. M., Chen, L. L., Scannell, C., Tager, I. B., Finkbeiner, W., Christian, D., Keller, T., Hearne, P. Q., Ferrando, R., and Welch, B. 1997. Airway inflammation and responsiveness to ozone in normal and asthmatic subjects. In Effects of ozone on normal and potentially sensitive subjects, Research Report Number 78, June. Cambridge, MA: Health Effects Institute. pp. 1-37.
4. Barton, H., Cogliano, J., Firestone, M. P., Flowers, L., Setzer, R. W., Valcovic, L., and Woodruff, T. 2005. Supplemental guidance for assessing susceptibility from early-life exposure to carcinogens. EPA/630/R-03/003F. Risk Assessment Forum, U.S. Environmental Protection Agency, Washington, DC, March. http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=160003, accessed 12/19/06.
5. Burmaster, D. E., and Thompson, K. M. 1999. Using animated probability plots to explore the suitability of mixture models with two component distributions. Risk Anal. 19:1185-1192.
6. Burmaster, D. E., and Wilson, A. M. 2000. Fitting second-order finite mixture models to data with many censored values using maximum likelihood estimation. Risk Anal. 20:261-271.
7. Evans, J. S., and Baird,, S. J. S. 1998. Accounting for missing data in noncancer risk assessment. Hum. Ecol. Risk Assess. 4:291-317.
8. Ginsberg, G., Hattis, D., Sonawane, B., Russ, A., Banati, P., Kozlak, M., Smolenski, S., and Goble, R. 2002. Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. Toxicol. Sci. 66:185-200.
9. Ginsberg, G., Hattis, D., Russ, A., and Sonawane, B. 2005. Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in the elderly. Environ. Health Perspect. 113:1243-1249.
10. Hanania, N. A., Tarlo, S. M., Silverman, F., Urch, B., Senathirajah, N., Zamel, N., and Corey, P. 1998. Effect of exposure to low levels of ozone on the response to inhaled allergen in allergic asthmatic patients. Chest 114,:752-756.
11. Hattis, D. 2003. The conception of variability in risk analyses - Developments since 1980. In Risk analysis and society in the 21st century: An interdisciplinary characterization of the field, eds. T. L. McDaniels and M. J. Small, pp. 15-45. Cambridge, MA: Cambridge University Press.
12. Hattis, D. 2004. Role of dosimetric scaling and species extrapolation in evaluating risks across life stages. III. Pharmacokinetic dosimetric considerations in pregnancy. Final report to the U.S. Environmental Protection Agency under RFQ no. DC-03-0000. Washington, DC: U.S. Environmental Protection Agency.
13. Hattis, D., and Anderson, E. 1999. What should be the implications of uncertainty, variability, and inherent 'biases'/'conservatism' for risk management decision making? Risk Anal. 19:95-107.
14. Hattis, D., and Burmaster, D. E. 1994. Assessment of variability and uncertainty distributions for practical risk analyses. Risk Anal. 14:713-730.
15. Hattis, D., and Lynch, M. K. 2006. Interspecies differences and human interindividual variability in tissue-level pharmacokinetic parameters. Task 3 - Final report - Description and analyses of the databases. Report by Clark University to the U.S. Environmental Protection Agency under Purchase Order no. EP05W002147. http://www2.clarku.edu/faculty/dhattis/, accessed 12/19/06.
16. Hattis, D., and Lynch, M. K. 2007. Empirically observed distributions of pharmacokinetic and pharmacodynamic variability in humans - Implications for the derivation of single point component uncertainty factors providing equivalent protection as existing RfDs. In Toxicokinetics in risk assessment, eds. J. C. Lipscomb and E. V. Ohanian, pp. 69-93. New York: Marcel Dekker.
17. Hattis, D., and Russ, A. 2004. Role of dosimetric scaling and species extrapolation in evaluating risks across life stages. II. Pharmacokinetic dosimetric considerations in old age. Final report to the U.S. Environmental Protection Agency under RFQ Nno. DC-03-0000. Washington, DC: U.S. Environmental Protection Agency.
18. Hattis, D. Banati, P., Goble, R., and Burmaster, D. 1999. Human interindividual variability in parameters related to health risks. Risk Anal. 19:705-720.
19. Hattis, D., Russ, A., Goble, R., Banati, P., and Chu, M. 2001. Human interindividual variability in susceptibility to airborne particles. Risk Anal. 21:585-599.
20. Hattis, D., Baird, S., and Goble, R. 2002. A straw man proposal for a quantitative definition of the RfD, Drug Chem. Toxicol. 25:403-436.
21. Hattis, D., Ginsberg, G, Sonawane, B., Smolenski, S., Russ, A., Kozlak, M, and Goble, R. 2003. Differences in pharmacokinetics between children and adults - II. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling, Risk Anal. 23:117-142.
22. Hattis, D., Goble, R., Russ, A., Chu, M, and Ericson, J. 2004. Age-related differences in susceptibility to carcinogenesis - A quantitative analysis of empirical animal bioassay data. Environ. Health Perspect. 112:1152-1158.
23. Hattis, D., Goble, R., and Chu, M. 2005. Age-related differences in susceptibility to carcinogenesis. II. Approaches for application and uncertainty analyses for individual genetically acting carcinogens. Environ. Health Perspect. 113:509-516.
24. Meek, M. E., Renwick, A., Ohanian, E., Dourson, M., Lake, B., Naumann, B. D., and Vu, V. 2002. Guidelines for application of chemical-specific adjustment factors in dose/concentration-response assessment. International Programme on Chemical Safety. Toxicology 27(181-182):115-120.
25. O'Connor, G., Sparrow, D. Taylor, D., Segal, M., and Weiss, S. 1987. Analysis of dose-response curves to methacholine: An approach suitable for population studies, Am. Rev. Respir. Dis. 136:1412-1417.
26. Office of Environmental Health Hazard Assessment. 1996. Technical support document for exposure assessment and stochastic analysis. Oakland: California Environmental Protection Agency, December. www.calepa.cahwnet.gov/ oehha.
27. Paoletti, P., Carrozzi, L., Viegi, G., Modena, P., Ballerin, L., Di Pede, F., Grado, L., Baldacci, S., Pedreschi, M., Vellutini, M., Paggiaro, P., Mammini, U., Fabbri, L., and Giuntini, C. 1995. Distribution of bronchial responsiveness in a general population: Effect of sex, age, smoking, and level of pulmonary function, Am. J. Respir. Crit. Care Med. 151:1770-1777.
28. Price, P. S., Swartout, J. C., Schmidt, C., and Keenan, R. E. 2001. Characterizing inter-species uncertainty using data from studies of anti-neoplastic agents in animals and humans. Manuscript available at http://www2.clarku.edu/faculty/dhattis.
29. Rhomberg, L. R., and Wolff, S. K. 1998. Empirical scaling of single oral lethal doses across mammalian species based on a large database. Risk Anal. 18:741-753.
30. Roeder, K. 1994. A graphical technique for determining the number of components in a mixture of normals. J. Am. Stat. Assoc. 89:487-495.
31. Sears, M., Jones, D. T., Holdaway, M. D., Hewitt, C. J., Flannery, E. M., Herbison, G. P., and Silva, P. A. 1986. Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children. Thorax 41:283-289.
32. Shlyakhter, A. I. 1994. An improved framework for uncertainty analysis: Accounting for unsuspected errors. Risk Anal. 14:441-447.
33. Tashkin, D. P., Altose, M. D., Connett, J. E., Kanner, R. E., Lee, W. W., and Wise, R. A. 1996. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 153:1802-1811.
34. Thompson, K. M. 1999. Developing univariate distributions from data for risk analysis. Hum. Ecol. Risk Assess. 5:755-783.